The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Images in Clinical Medicine
PreviousPrevious
Volume 353:2176 November 17, 2005 Number 20
NextNext

Lentigo Maligna

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF

Commentary
-Letters

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-PubMed Citation
Figure Removed (Available Only in the Full Text)
View larger version (42K):
[in this window]
[in a new window]
 
An 81-year-old woman was referred for treatment of two asymmetric, poorly circumscribed pigmented macules on the left cheek. The pigmentation was variegated, ranging from light brown to retiform areas of black (Panel A). The histopathological diagnosis was lentigo maligna, a form of melanoma in situ. Instead of treatment with a large excision, imiquimod cream (5 percent concentration) was applied for eight hours twice weekly for 12 weeks. During the treatment, the patient reported only minor localized skin irritation. After three months of treatment, the macules completely disappeared, as confirmed by two skin biopsies. One year later, the skin was without . . . [Full Text of this Article]

 

Related Letters:

Lentigo Maligna and Radiotherapy
Wilson L. D., Noël B.
Extract | Full Text | PDF  
N Engl J Med 2006; 354:1322, Mar 23, 2006. Correspondence

This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.